Jenscare Scientific Co. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-295.00
-201.00
-439.00
-531.00
-605.00
-336.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
72.00
-57.00
-43.00
0.00
-6.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-82.00
-235.00
-245.00
-191.00
-163.00
-52.00
Cash Flow from Investing Activities
6.00
6.00
396.00
-168.00
-572.00
7.00
Cash Flow from Financing Activities
-20.00
-120.00
61.00
225.00
1,288.00
430.00
Net Cash Inflow / Outflow
-106.00
-348.00
221.00
-85.00
544.00
385.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-9.00
0.00
9.00
49.00
-8.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Jenscare Scientific Co. Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-295.753861289543
124.377478247954
-419.00
-337.79%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
72.076338694855
-10.9667003247472
82.00
757.23%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-82.736118905688
139.039149696753
-221.00
-159.51%
Cash Flow from Investing Activities
6.46918190636046
21.227375935154
-15.00
-69.52%
Cash Flow from Financing Activities
-20.9562450924733
-207.446545828453
187.00
89.90%
Net Cash Inflow / Outflow
-106.918821026061
-2.58116562231985
-104.00
-4042.27%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-9.69563893426027
44.5988545742265
-53.00
-121.74%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 64.92% vs 4.04% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-82.74
-235.88
64.92%






